LINDSEY MCLEAR: Open Payments
NPI 1366935298 · OGDENSBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 28 payments from 21 companies in 2025. Trend: 2023 $743 · 2024 $811 · 2025 $811
Food & beverage: $631Education: $180
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $126 |
| Incyte Corporation | 2 | $102 |
| SEAGEN INC. | 1 | $96 |
| EMD Serono, Inc. | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Eisai Inc. | 1 | $34 |
| Pharmacosmos Therapeutics Inc. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
Products named: DATROWAY, Enhertu, KEYTRUDA, LIBTAYO, Lenvima, MONOFERRIC, RYBREVANT, XPOVIO.
Industry payments across NY — which companies pay providers there.
